Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer

Gastric cancer is a fatal gastrointestinal cancer with high morbidity and poor prognosis. The dismal 5- year survival rate warrants reliable biomarkers to assess and improve the prognosis of gastric cancer.